Bristol-Myers Squibb Company (BRM BE) stock market data APIs
€44.9901
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
Bristol-Myers Squibb Company Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BRM.BE.
Prev. Close
44.9901
Open
44.9901
High
44.9901
Low
44.9901
52 wk Range
36.675-56.0332
Market Cap
110 771 M
Dividends (Yield)
0.0157
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bristol-Myers Squibb Company data using free add-ons & libraries
Get Bristol-Myers Squibb Company Fundamental Data
Bristol-Myers Squibb Company Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bristol-Myers Squibb Company News
New
Great week for Bristol-Myers Squibb Company (NYSE:BMY) institutional investors after losing 0.8% over the previous year
Key Insights Institutions' substantial holdings in Bristol-Myers Squibb implies that they have significant influence over the company's share price A total of 24 investors have a majority stake in th...
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing
Bristol Myers Squibb (BMY) ended the recent trading session at $54.19, demonstrating a +1.61% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of ...
Trump reaches deal with 9 drug companies to lower prices
President Trump announced deals with nine major drug makers in a move to reduce pharmaceutical prices, granting a three-year break on trade tariffs if they invest more into US manufacturing. Market Do...
Cytokinetics Wins FDA Approval For Its First Drug, Taking On Bristol Myers
Cytokinetics won its first Food and Drug Administration approval late Friday, leading shares to jump in after-hours action. Continue Reading
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
